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We would like to thank Laptook et al. (1) for their response
to our ‘Major concerns about late hypothermia study’ (2).
However, their response suggests that the difference
between their opinion and ours arises because we are using
frequentist statistics and they are using Bayesian. This is not
the case. There is indeed general concern at present about
the potential misuse of p-values in frequentist statistical
practice. We agree that generally in situations where a
limited number of observations are available, the usual
frequentist requirement for the significance probability to
be lower than 0.05 is too strict. Results with a significance
probability of 0.10 or even 0.15 may also give valuable
information, and correspondingly a confidence interval
(frequentist) or credibility interval (Bayesian) of 0.95 is
sometimes too strict.
The heart of the matter is whether the observation that 19
of 78 neonates in group 1 (with cooling initiated in the time
window from 6 to 24 hours after birth) showed adverse
outcomes can be said to indicate that the associated
probability p1 is smaller than the corresponding probability
p0 in the control group, where 22 of 79 showed adverse
outcomes. The original JAMA paper (3) discussed this in
terms of the relative risk rr = p1/p0, and the question is
whether there are any grounds to claim, with any mean-
ingful confidence or credibility (to use the relevant fre-
quentist and Bayesian terms), that rr is smaller than 1.
Our primary analysis was indeed frequentist, demon-
strating that with sample sizes 79 and 78 there can be no
meaningful statistical difference between the probability
estimates 19/78 = 0.244 and 22/79 = 0.278. The close
proximity of these two estimates can be assessed in several
ways, including a p-value far above the customary levels for
significance (p = 0.75), and a confidence curve with the
value rr = 1 in the middle with a 95 per cent confidence
interval (0.51, 1.48) (see Fig. 1 in our previous commu-
nication (2)).
We have nothing against Bayesian analyses in general,
and we agree that Laptook et al.’s ‘neutral’ unimodal prior
with rr = 1 is sensible if no prior knowledge on late cooling
is available. The detailed shape and especially the tails of
this prior probability distribution are of course rather
uncertain. As our figure clearly shows, Laptook et al.’s
results give little support for the claim that p1 is smaller
than p0 (i.e. that the relative risk parameter rr = p1/p0
above is smaller than 1). We have also performed a
sensitivity analysis on the results of the trial. We moved
two infants from the control group to the cooled group, so
that the outcome was death or disability for 21 of 78 infants
in the cooled group and 20 of 79 in the control group. These
results would indicate a slightly better outcome for the
control group, which is certainly possible if there is no real
difference between the two groups.
The figure displays Laptook et al.’s Bayesian prior prob-
ability distribution (in red) and two posterior probability
distributions (in black) for the rr parameter. The solid black
curve is the posterior using the observed data, while the
dashed black curve is the posterior using the hypothetical
outcomes from the sensitivity analysis. The 95 per cent
credibility intervals for rr are (0.61, 1.40) and (0.68, 1.58),
respectively, for the two posterior distributions. rr = 1.00 is
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close to the middle (median) in all three cases. Even
intervals with 70% credibility or less would cover rr = 1.00
in all three distributions, indicating that there is no real
difference between the two groups.
In the JAMA paper Laptook et al. (3) write ‘The prob-
ability that death or disability in cooled infants was at least
1, 2, or 3% less than non-cooled infants was 71, 64, and
56%, respectively’, and further: cooling ‘compared with
non-cooling resulted in a 76% probability of any reduction
in death or disability’. Unfortunately, we have not been able
to reproduce these numbers using Laptook et al.’s ‘neutral’
prior. According to our Bayesian calculations, the proba-
bility that death or disability in cooled infants was at least 1,
2, or 3% less than in non-cooled infants was 64, 62 and
60%, respectively, and cooling resulted in a 65% probability
of any reduction in death or disability. Using the posterior
distribution from the sensitivity analysis, the probabilities
were 41, 39, 37 and 43%, respectively. Two observations
can be made from these numbers. There is always a positive
probability that death and disability in cooled infants is less
than in non-cooled infants, even when the trial results
indicate the opposite, but these probabilities vary greatly
with small changes in the real outcome. We also see that the
two posterior distributions are not very different from
the prior distribution. In fact, they are heavily influenced by
the prior and only to a limited degree by the results from the
trial. The probabilities in the tails of the posterior distribu-
tion are also strongly influenced by the shape and width of
the prior distribution, of which we have limited knowledge.
The very uncertain tail probabilities in the posterior
distribution should therefore definitely not be used as
arguments for late cooling.
If the times when the cooling started had been given for
all infants, other relevant statistical analyses could have
been performed [e.g. logistic regression with time as a
covariate or a Bayesian analysis with the results from late
cooling of rat pups and foetal sheep as basis for a prior (2)].
Although only tested in rats, one study showed that very
severe injury increased more if cooling started 12 hour after
the experimental insult (4). The current patient cohorts
undergoing therapeutic hypothermia, including that in
Laptook et al.’s (3) ‘Late hypothermia trial’ are all milder
than the original trial cohorts that showed that therapeutic
hypothermia was effective. As an example; in the 2005
NICHD whole body cooling trial, the non-cooled group
had 37% mortality and 40% disability in survivors (5). In
the late hypothermia trial, the mortality in the non-cooled
group was 11, and 19% of the survivors had disabilities (3).
We do not agree that there is evidence for suggesting
starting hypothermia treatment late. Also, one does not
know how high the risk for harm would be (6) if one expose
rather mild HIE infants to 3 days of cooling and intensive
care.
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Figure 1 Red curve: The neutral prior probability distribution from Laptook
et al. (3) with median rr = 1.0. The distribution is normal in log space with
SD = 0.35. Solid black curve: Posterior distribution calculated from the prior
and the results from the trial. Dashed black curve: Posterior distribution
calculated from the hypothetical results were two infants with adverse outcome
were moved from the non-cooled group to the cooled group as a sensitivity test.
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